HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer
Clinical trial NCT05728619 · UNKNOWN
Trial details
- NCT number
- NCT05728619
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-03
- Primary completion
- 2024-08-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.